INTRODUCTION

3
Valerie et al, (1) stably transfected into HeLa cells a construct with the long terminal repeat (LTR) of the human immunodeficiencyvirus (HIV) type 1 driving transcription of the chloramphenicol acetyl transferase (CAT) reporter gene. Several groups have used this system to explore the ability of DNA damaging agents and other agents to induce HIV expression (2) (3) (4) (5) (6) . The HIV promoter is activitated in vivo and i n vitro in response to DNA damaging and tumor promoting agents , though the mechanism(s) by which this OCCLUS is not known. In these experiments, we set out to determine whether the HIV-LTR is induced following exposure to DNA damaging agents, which act through I different mechanisms. Doxorubicin (DOX) or adrimycin, is a chemotherapeutic agent widely used for a broad variety of different neoplasias (10-12). In the past, cisplatin, DOX, bleomycin, and vincristine have been used as therapy for acquired immune deficiency syndrome (AIDS)-related Karposi sarcoma and other germ cell neoplasms (13). DOX has been shown to intercalate into DNA and can cause single-strand breaks, double-strand breaks, and sister chromatid exchange. This class of drug (anthracylines) can also interact with the cell membrane and participate in oxidation-reduction reactions (14) . The cell cultures were maintained in Dulbecco's Modified Eagle's Medium containing 4500 mg/L D-glucose, 10% fetal bovine serum (GIBCO, Gaithersburg, MD) supplemented with sodium bicarbonate (0.73 mg/mL), penicillin (100 units/mL), streptomycin (100 units/mL), and geneticin (0.5 mg/ml). Cultures were grown in 100 x 20 mm Petri plates in 10 mL of medium at 37 "C under 2.0% CO,. Cell viability was determined by trypan blue dye exclusiofi.
5-Fluorouracil (5-
CAT assay. Plates were harvested by washing with cold Ca2'-and Me-free phosphate-buffered s h e (PBS), and the monolayer was trypsonized from the plates, washed, and counted on a hemocytometer as previously described appropriate dilutions were made by dilution in PBS and added directly to the culture media. We noted some batch-to-batch variation in the ability of DOX to induce HW-Lm-CAT. This may be due to the fact that the drug is easily inactiviated by heat or light.
5-FU.
The drug was obtained from Sigma Chemical Company. A stock solution at a concentration of 50 mg/mL was made, and the appropriate dilutions were made by dilution in PBS and added directly to the culture media.
Salicylic acid. Salicylic acid (2-hydroxy benzoic acid) was obtained from Sigma Chemical Company. It was dissolved in PRS and added to cultures at 2.5 mg/mL, a concentration shown previously by our group to inhibit cisplatin-and UV-mediated HIV-LTR induction (1 6).
Ultraviolet radiation. Exposures to 254 nm UV radiation were administered by using a General Electric (GE30T8) 30-W germicidal lamp that was contained in a sterile hood. The irradiations were at a distance of 55.6 cm from the source. The dose rate for all exposures to W C radiation was 2.5 Jm2sec-1. The media were removed from the 100-mrn plates, and the plates were washed once with cold PBS and irradiated without covers. The media were replaced immediately after irradiation.
RESULTS
Both DOX and 5-FU caused increased activation of the HW-LTR; however, the patterns and amounts of induction that they exhibited were different. Figure 1 demonstrates that DOX showed maximal expression of the CAT reporter gene at a concentration of 1 pg/mL at 24 h following addition of drug to culture medium. A 10-fold increase or decrease in concentration of the drug showed expression levels similar to that of controls. This optimum inducing concentration of the drug was then used to study the kinetics of the HIV-LTR induction. A 2-fold increase in expression was evident as early as 12 h ( Fig. 2) following DOX addition. Within the first 24 h, maximal induction (9-to 1 1-fold) was observed 24 h following drug addition; submzrdmal expression (7-fold) was detected 18 h following drug exposure. At a concentration of 0.5 pg/mL, there was a 1.5-fold increase in expression compared with controls, and at 0.1 pg/mL there was no change compared with controls. The temporal expression shown in Figure 2 is consistent with results reported in the literature for the effects of other DNA damaging agents on HIV-LTR-CAT expression (1) (2) (3) (4) (5) (6) (7) 14, (16) (17) (18) .
In the next series of experiments, we examined the effects of DOX combined with U V exposure (another HIV-LTR inducer) on the induction of CAT expression from the HW-LTR. Figure 3 demonstrates 4-to 5-fold induction of CAT expression 48 h after exposure to the optimum concentration of DOX (1 pg/mL) as well as 6-fold induction 24 h following U V exposure.
These are expected based on previous data in the literature (1-9) as well as we set out to determine whether salicylic acid also inhibits DOX-mediated induction. Figure 4 demonstrates that salicylic acid (2.5 mg/mL) administered up to 6 h following DOX treatment (1 pg/mL) causes repression of the HIV-LTR induction. This time frame is consistent with studies that use W and cisplatin ( 16).
In hrther experiments, we examined the effects of another 
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-. addition of the drug to culture medium. 
